The antithrombotic effect of dextran-40 in man is due to enhanced fibrinolysis in vivo
Authors:
- Chris I. JonesCJChris I. Jones
- David A. PayneDPDavid A. Payne
- Paul D. HayesPHPaul D. Hayes
- A. Ross NaylorANA. Ross Naylor
- Peter R.F. BellPBPeter R.F. Bell
- Mathew M. ThompsonMTMathew M. Thompson
- Alison H. GoodallAGAlison H. Goodall
- 1 September 2008
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 48 (3) , 715-722
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Reducing the risk of carotid surgery: A 7-year audit of the role of monitoring and quality control assessmentJournal of Vascular Surgery, 2000
- Transcranial Doppler-directed Dextran-40 Therapy is a Cost-effective Method of Preventing Carotid Thrombosis After Carotid EndarterectomyEuropean Journal of Vascular and Endovascular Surgery, 2000
- Effect of Dextran on Factor Vlll/von Willebrand Factor Structure and FunctionThrombosis and Haemostasis, 1985
- Exposure of platelet fibrinogen receptors by ADP and epinephrine.Journal of Clinical Investigation, 1979
- Suppressive Effect of Dextran on Platelet AdhesivenessThrombosis and Haemostasis, 1966
- The Effect of Dextran of Various Molecular Weight on the Coagulation in DogsThrombosis and Haemostasis, 1961
- DEXTRAN AND PROLONGED BLEEDING TIMEJAMA, 1958
- Metabolic and Hemodynamic Changes Induced by the Prolonged Administration of DextranCirculation, 1955
- An Hemostatic Defect Associated with Dextran InfusionExperimental Biology and Medicine, 1954
- Dextran as a Substitute for PlasmaNature, 1945